SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-13-006686
Filing Date
2013-04-11
Accepted
2013-04-11 15:22:36
Documents
3
Period of Report
2013-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 6325
2 POWER OF ATTORNEY ex-24sofinnovacapitalivfcpr.txt EX-24 4205
3 POWER OF ATTORNEY ex-24sofinnovapartners.txt EX-24 4121
  Complete submission text file 0001179110-13-006686.txt   16688
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Reporting) CIK: 0001441261 (see all company filings)

State of Incorp.: XX
Type: 3 | Act: 34 | File No.: 001-35869 | Film No.: 13756135

Mailing Address 707 STATE ROAD NEW JERSEY NJ 08540
Business Address 707 STATE ROAD NEW JERSEY NJ 08540 908-741-4323
Omthera Pharmaceuticals, Inc. (Issuer) CIK: 0001477598 (see all company filings)

IRS No.: 263797738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35869 | Film No.: 13756136